Systemic immune activation in hereditary cancer predisposition syndromes: a cross-sectional study.

Kelemen I, Horti-Oravecz K, Bozsik A, Pócza T, Papp J, Likó I, Neuperger P, Balogh F, Kemény Á, Nagy P, Vereczki V, Pósa SP, Pongor LS, Kövesdi D, Butz H, Patócs A, Szebeni GJ, Grolmusz VK

Open source

DOI
10.1186/s12916-026-05188-x
Published
2026 Aug 25
Container
BMC medicine
Publisher
Not recorded
Open access
yes

Credibility signals

limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1186/s12916-026-05188-x,
  title = {Systemic immune activation in hereditary cancer predisposition syndromes: a cross-sectional study.},
  author = {Kelemen I and Horti-Oravecz K and Bozsik A and Pócza T and Papp J and Likó I and Neuperger P and Balogh F and Kemény Á and Nagy P and Vereczki V and Pósa SP and Pongor LS and Kövesdi D and Butz H and Patócs A and Szebeni GJ and Grolmusz VK},
  year = {2026},
  journal = {BMC medicine},
  doi = {10.1186/s12916-026-05188-x},
  url = {https://doi.org/10.1186/s12916-026-05188-x}
}

RIS

TY  - JOUR
TI  - Systemic immune activation in hereditary cancer predisposition syndromes: a cross-sectional study.
AU  - Kelemen I
AU  - Horti-Oravecz K
AU  - Bozsik A
AU  - Pócza T
AU  - Papp J
AU  - Likó I
AU  - Neuperger P
AU  - Balogh F
AU  - Kemény Á
AU  - Nagy P
AU  - Vereczki V
AU  - Pósa SP
AU  - Pongor LS
AU  - Kövesdi D
AU  - Butz H
AU  - Patócs A
AU  - Szebeni GJ
AU  - Grolmusz VK
PY  - 2026
JO  - BMC medicine
DO  - 10.1186/s12916-026-05188-x
UR  - https://doi.org/10.1186/s12916-026-05188-x
ER  - 

APA

I, K., K, H., A, B., T, P., J, P., I, L., P, N., F, B., Á, K., P, N., V, V., SP, P., LS, P., D, K., H, B., A, P., GJ, S., & VK, G. (2026). Systemic immune activation in hereditary cancer predisposition syndromes: a cross-sectional study.. BMC medicine. https://doi.org/10.1186/s12916-026-05188-x

Source records